Tumor Necrosis Factor Alpha and Interleukin-6 Facilitate Corneal Lymphangiogenesis in Response to Herpes Simplex Virus 1 Infection
暂无分享,去创建一个
[1] K. Maruyama,et al. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases , 2013, Progress in Retinal and Eye Research.
[2] P. Rama,et al. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. , 2013, Investigative ophthalmology & visual science.
[3] R. Hendricks,et al. Herpes keratitis , 2013, Progress in Retinal and Eye Research.
[4] W. Min,et al. Functional analyses of TNFR2 in physiological and pathological retina angiogenesis. , 2013, Investigative ophthalmology & visual science.
[5] N. Mukaida,et al. Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization. , 2012, Investigative ophthalmology & visual science.
[6] W. Halford,et al. The Herpes Simplex Virus-1 Transactivator Infected Cell Protein-4 Drives VEGF-A Dependent Neovascularization , 2011, PLoS pathogens.
[7] R. Dana,et al. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes , 2011, The Journal of experimental medicine.
[8] D. Carr,et al. VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesis , 2009, The Journal of experimental medicine.
[9] 寺坂 祐樹. Induction of IL-6 in transcriptional networks in corneal epithelial cells after herpes simplex virus type 1 infection , 2010 .
[10] D. McDonald,et al. TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. , 2009, The Journal of clinical investigation.
[11] K. Alitalo,et al. Molecular biology and pathology of lymphangiogenesis. , 2008, Annual review of pathology.
[12] V. Goldberg,et al. Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. , 2007, Bone.
[13] N. Van Rooijen,et al. Tumor Necrosis Factor (TNF) Protects Resistant C57BL/6 Mice against Herpes Simplex Virus-Induced Encephalitis Independently of Signaling via TNF Receptor 1 or 2 , 2006, Journal of Virology.
[14] J. Martin Collinson,et al. Corneal avascularity is due to soluble VEGF receptor-1 , 2006, Nature.
[15] Ashok Kumar,et al. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells , 2006, Immunology.
[16] L. Debusk,et al. Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis , 2004 .
[17] K. Hashimoto,et al. Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. , 2004, The Journal of general virology.
[18] J. Kaczorowski,et al. Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada , 2003, Journal of Clinical Microbiology.
[19] T. L. Keadle,et al. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. , 2000, Investigative ophthalmology & visual science.
[20] M. Dana,et al. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. , 1999, Investigative ophthalmology & visual science.
[21] C. Foster,et al. Cytokine mRNA in BALB/c mouse corneas infected with herpes simplex virus , 1999, Eye.
[22] M. Dana,et al. TNF-alpha regulates corneal Langerhans cell migration. , 1999, Journal of immunology.
[23] M. Dana,et al. TNF-α Regulates Corneal Langerhans Cell Migration , 1999, The Journal of Immunology.
[24] I. Campbell,et al. Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. , 1999, Journal of neurovirology.
[25] P. Hodgkin,et al. Generation of Splenic Follicular Structure and B Cell Movement in Tumor Necrosis Factor–deficient Mice , 1998, The Journal of experimental medicine.
[26] D. Carr,et al. Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. , 1998, Journal of immunology.
[27] A. Cunningham,et al. In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? , 1998, The Journal of infectious diseases.
[28] J. Kriesel,et al. Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. , 1997, The Journal of infectious diseases.
[29] S. Kaufmann,et al. Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. , 1994, Trends in microbiology.
[30] H. Staats,et al. Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. , 1993, Journal of immunology.
[31] L. Melton,et al. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. , 1989, Archives of ophthalmology.
[32] W. Risau,et al. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[33] J W DUGGAN,et al. Herpes simplex virus. , 1961, Transactions of the Canadian Ophthalmological Society.